What were Merck's Q1 2026 revenues?

Merck's Q1 2026 revenues were $16.29 billion, up 4.9% year-over-year.

Did Merck beat analyst expectations?

Yes, Merck beat revenue expectations and its non-GAAP loss per share was 13.2% better than consensus estimates.

What is Merck's FY2026 revenue guidance?

Merck expects FY2026 revenue of approximately $66.4 billion, close to analyst estimates.

What drove Merck's revenue growth?

Growth was driven by strong performance in the pharmaceutical and healthcare segments, along with cost-cutting measures.

Merck (MRK) Beats Q1 2026 Revenue Estimates, Sales Up 4.9%

Merck (NYSE:MRK) reported Q1 2026 results that beat Wall Street's revenue expectations, with sales rising 4.9% year-over-year to $16.29 billion. The company also posted a non-GAAP loss of $1.28 per share, which was 13.2% above analyst consensus estimates.

Global pharmaceutical company Merck (NYSE:MRK) reported Q1 2026 results that surpassed Wall Street's revenue expectations. Sales reached $16.29 billion, up 4.9% year-over-year. The company posted a non-GAAP loss of $1.28 per share, which was 13.2% better than analyst consensus estimates.

Key Financial Results

Metric	Q1 2026	Q1 2025	Change
Revenue	$16.29B	$15.53B	+4.9%
Non-GAAP EPS	($1.28)	N/A	Beat by 13.2%

Highlights from the Release

Merck attributed the revenue growth to strong performance in its pharmaceutical and healthcare segments, despite competitive pressures in certain markets. The company also noted improved profit margins due to cost-cutting measures.

Forward Guidance

Merck expects full-year 2026 revenue to be approximately $66.4 billion, close to analyst estimates. This suggests the company anticipates continued growth in the second half of the year.

Stock Impact

The report did not include an immediate stock reaction for MRK. However, beating expectations could support the stock in upcoming sessions.

What This Means for Investors

Merck's revenue beat reflects the strength of its core business. Guidance near estimates indicates expected stability. Investors should monitor the company's performance in coming quarters and the impact of external factors such as currency exchange rates and competition.